This article provides an understanding of the issues and steps that are required for negotiating a disease management contract. Because most of the author's experience derives from representing pharmaceutical companies and other provider driven entities, the tenor of the comments often reflects that perspective on negotiations. This article focuses on disease management contracting whereby a provider network or case manager assumes risk relating to the cost of providing care to a certain type of patient.
Stewart EE. Stewart EE. J Health Care Finance. 1996 Spring;22(3):75-83. J Health Care Finance. 1996. PMID: 8777711
Shapleigh C. Shapleigh C. Healthc Financ Manage. 1993 Aug;47(8):26-8, 30. Healthc Financ Manage. 1993. PMID: 10145851
Ballun JE. Ballun JE. QRC Advis. 1998 Apr;14(6):1-8. QRC Advis. 1998. PMID: 10177474 No abstract available.
Gilden LJ, Puterbaugh JB. Gilden LJ, et al. Gastroenterol Clin North Am. 1997 Dec;26(4):811-21. doi: 10.1016/s0889-8553(05)70335-6. Gastroenterol Clin North Am. 1997. PMID: 9439957 Review.
Scammon DL, Fuller DA. Scammon DL, et al. J Ambul Care Mark. 1992;5(1):209-19. J Ambul Care Mark. 1992. PMID: 10122753 Review.